Balanced news tone
News Sentiment
6990 sentiment intelligence
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+3.5% over one week, +24.4% over four weeks, trend active, and materially above fair value.
Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 02:34
- Source
- marketscreener.com
Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap On New Cancer Cell Research?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- simplywall.st
Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Down 14.8% After ASCO NSCLC Data Spotlight - Has The Bull Case Changed?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2026 07:00
- Source
- simplywall.st
Why Sichuan Kelun-Biotech (SEHK:6990) Is Down 8.2% After ASCO Lung Cancer Data Upside Surprise And What's Next
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Market source
Is It Time To Reassess Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) After Recent Share Price Weakness?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- simplywall.st